BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 12430363)

  • 21. 2004: the end of the beginning for universal coverage?
    Pogue JF
    Healthc Leadersh Manag Rep; 2003 Dec; 11(12):15. PubMed ID: 14986344
    [No Abstract]   [Full Text] [Related]  

  • 22. PBMs get new role. Seen as key to drug cost control under new benefit.
    Becker C
    Mod Healthc; 2003 Dec 22-29; 33(51):31, 33. PubMed ID: 14723089
    [No Abstract]   [Full Text] [Related]  

  • 23. The challenge of expanding health benefits for the aged.
    Elwood TW
    J Allied Health; 2000; 29(4):189-95. PubMed ID: 11147184
    [No Abstract]   [Full Text] [Related]  

  • 24. Medicare Part D--the product of a broken process.
    Slaughter LM
    N Engl J Med; 2006 Jun; 354(22):2314-5. PubMed ID: 16738267
    [No Abstract]   [Full Text] [Related]  

  • 25. Reforming patient assistance programs: perfect world meets real world.
    Weinberg M
    Health Aff (Millwood); 2009; 28(3):839-42. PubMed ID: 19414895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stakes raised for reform.
    Carroll J
    Manag Care; 2003 Feb; 12(2):22-8. PubMed ID: 12658854
    [No Abstract]   [Full Text] [Related]  

  • 27. Massachusetts health care reform: a look at the issues.
    Holahan J; Blumberg L
    Health Aff (Millwood); 2006; 25(6):w432-43. PubMed ID: 16973652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covering prescription drugs under Medicare: for the good of the patients.
    Holmer AF
    Health Aff (Millwood); 1999; 18(4):23-4. PubMed ID: 10425840
    [No Abstract]   [Full Text] [Related]  

  • 29. Bitter pills.
    Carpenter D
    Hosp Health Netw; 2000 Aug; 74(8):48-52. PubMed ID: 10983224
    [No Abstract]   [Full Text] [Related]  

  • 30. Dueling spending projections. OMB pins $534 billion price tag on Rx benefit.
    Tieman J
    Mod Healthc; 2004 Feb; 34(5):10-1. PubMed ID: 14974299
    [No Abstract]   [Full Text] [Related]  

  • 31. Medicare/prescription drug benefit in the crossfire.
    Halamandaris VJ
    Caring; 2004 Jun; 23(6):56. PubMed ID: 15270333
    [No Abstract]   [Full Text] [Related]  

  • 32. Congress shapes a prescription drug benefit.
    Baxter MD
    Oncologist; 2003; 8(4):392-4. PubMed ID: 12897337
    [No Abstract]   [Full Text] [Related]  

  • 33. Bridging the gap: state and private industry response to the lack of a Medicare outpatient prescription drug benefit.
    Goldstein WC; Peterson KA
    Manag Care Interface; 2002 Jun; 15(6):55-8. PubMed ID: 12087608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The new Medicare prescription-drug benefit--a pure power play.
    Iglehart JK
    N Engl J Med; 2004 Feb; 350(8):826-33. PubMed ID: 14973209
    [No Abstract]   [Full Text] [Related]  

  • 35. Can we afford all this?
    Dickerson JF
    Time; 2003 Dec; 162(23):48-51. PubMed ID: 14712554
    [No Abstract]   [Full Text] [Related]  

  • 36. The placebo effect. Congress hopes you won't notice its prescription-drug plans are meant to help candidates, not patients.
    Tumulty K
    Time; 2002 Aug; 160(7):26. PubMed ID: 12195650
    [No Abstract]   [Full Text] [Related]  

  • 37. Incremental health care reform.
    Brennan TA; Mello MM
    JAMA; 2009 May; 301(17):1814-6. PubMed ID: 19417200
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceuticals and medical devices: Medicare Part D.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403844
    [No Abstract]   [Full Text] [Related]  

  • 39. The Medicare Prescription Drug Improvement and Modernization Act: prescription drugs and academic medicine.
    Frencher SK; Glied S
    Acad Med; 2006 Sep; 81(9):812-6. PubMed ID: 16936488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bitter pill. Why a Medicare prescription-drug benefit isn't good for our health.
    Birnbaum JH
    Fortune; 2003 Jul; 148(1):36. PubMed ID: 12858794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.